A Genetically Engineered Macrophage-Derived Vesicular Nanodecoy Targeting the CD47/SIRPα Axis for Reinforced Tumor Radioimmunotherapy

Journal:

ACS Nano

Published:

2026-05-28

DOI:

10.1021/acsnano.6c06363

Affiliations:

3

Authors:

9

Go to article

Institutions	Authors	Share
Shandong First Medical University and Shandong Academy of Medical Sciences (SFMU), China	5.500000	0.61
State Key Laboratory of Flexible Electronics (LoFE), China	2.000000	0.22
Hunan University of Science and Technology (HNUST), China	1.500000	0.17

Interested in Oncology and Carcinogenesis?